These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 7344514)

  • 61. In vivo covalent binding of chemicals to DNA as a short-term test for carcinogenicity.
    Lutz WK; Schlatter C
    Arch Toxicol Suppl; 1979; (2):411-5. PubMed ID: 288355
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair.
    Harris CC
    Carcinogenesis; 1989 Sep; 10(9):1563-6. PubMed ID: 2670300
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Detection of mammalian carcinogens with an immunological DNA synthesis-inhibition test.
    Heil J; Reifferscheid G
    Carcinogenesis; 1992 Dec; 13(12):2389-94. PubMed ID: 1473248
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Quantitative correlation of carcinogenic potency with four different classes of short-term test data.
    Travis CC; Wang LA; Waehner MJ
    Mutagenesis; 1991 Sep; 6(5):353-60. PubMed ID: 1795638
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Types and amounts of carcinogens as potential human cancer hazards.
    Weisburger JH; Williams GM
    Cell Biol Toxicol; 1989 Dec; 5(4):377-91. PubMed ID: 2627674
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules.
    Miller EC; Miller JA
    Cancer; 1981 May; 47(10):2327-45. PubMed ID: 7272889
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The distinct health risk analyses required for genotoxic carcinogens and promoting agents.
    Weisburger JH; Williams GM
    Environ Health Perspect; 1983 Apr; 50():233-45. PubMed ID: 6873017
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Application of biomarkers to risk assessment.
    Gaylor DW; Kadlubar FF; Beland FA
    Environ Health Perspect; 1992 Nov; 98():139-41. PubMed ID: 1486842
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The scientific basis for carcinogen detection and primary cancer prevention.
    Weinstein IB
    Cancer; 1981 Mar; 47(5 Suppl):1133-41. PubMed ID: 7237369
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The mode of action of organic carcinogens on cellular structures.
    Luch A
    EXS; 2006; (96):65-95. PubMed ID: 16383015
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MORPHEAFORM BCC OF ALA NASI: A SUCCESSFUL DERMATOSURGICAL APPROACH BY TRANSPOSITION FLAP FROM THE ADJACENT AREA. CONTAMINATION OF VENLAFAXINE, BISOPROLOL AND OLANZAPINE WITH NITROSAMINES/NDSRIS: THE MOST LIKELY CAUSE OF SKIN CANCER DEVELOPMENT AND PROGRESSION.
    Tchernev G; Lozev I; Ivanov L
    Georgian Med News; 2023 Sep; (342):26-29. PubMed ID: 37991952
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Trace elements and carcinogenicity: a subject in review.
    Mulware SJ
    3 Biotech; 2013 Apr; 3(2):85-96. PubMed ID: 28324563
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dose-response relationship for chemical carcinogenesis by genotoxic agents.
    Lutz WK
    Soz Praventivmed; 1991; 36(4-5):243-8. PubMed ID: 1750274
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mechanisms of chemical carcinogenesis.
    Miller EC; Miller JA
    Cancer; 1981 Mar; 47(5 Suppl):1055-64. PubMed ID: 7016297
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cancer risk related to genetic polymorphisms in carcinogen metabolism and DNA repair.
    Poulsen HE; Loft S; Wassermann K
    Pharmacol Toxicol; 1993; 72 Suppl 1():93-103. PubMed ID: 8474997
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Non-mutagenic carcinogens are primarily hydrophobic.
    McCoy GD; Rosenkranz HS; Klopman G
    Carcinogenesis; 1990 Jul; 11(7):1111-7. PubMed ID: 2372870
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A methodology for assessing carcinogenic hazards of chemicals.
    Brown HS; Bishop DR; West CR
    Toxicol Ind Health; 1986 Sep; 2(3):205-18. PubMed ID: 3787657
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Contribution of toxicology towards risk assessment of carcinogens.
    Kroes R
    Arch Toxicol; 1987; 60(1-3):224-8. PubMed ID: 3304212
    [TBL] [Abstract][Full Text] [Related]  

  • 79. DNA modification and repair in vivo: towards a biochemical basis of organ-specific carcinogenesis by methylating agents.
    Kleihues P; Hodgson RM; Veit C; Schweinsberg F; Wiessler M
    Basic Life Sci; 1983; 24():509-29. PubMed ID: 6860273
    [No Abstract]   [Full Text] [Related]  

  • 80. Quantitative correlation with carcinogenic potency of different short term tests.
    Parodi S; Taningher M; Boero P; Santi L
    Toxicol Pathol; 1984; 12(3):247-55. PubMed ID: 6515278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.